 PHILADELPHIA, July 28, 2022 GLOBE NEWSWIRE -- Passage Bio, Inc. NASDAQ: PASG, a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system CNS disorders, today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, August 4, 2022, to report its second quarter 2022 financial results and discuss recent business highlights. 